SlideShare une entreprise Scribd logo
1  sur  16
1
Marketing project report on customer
behaviour towards use of various
Over the counter (OTC) medicines
INTRODUCTION
 Over-the-counter (OTC) drugs are medicines sold directly to a
consumer without a prescription, from a healthcare professional, as
compared to prescription drugs , which may be sold only to
consumers possessing a valid prescription.
 OTC drugs are selected by a regulatory agency to ensure that they
are ingredients that are safe and effective when used without
a physician's care.
2
3
Two post-1938 regulatory pathways exist for the legal marketing of OTC
products:
1. marketing in compliance with an OTC drug monograph
2. marketing under the authority of an approved product-specific new drug
application (NDA), or an abbreviated new drug application (ANDA)
REGULATORY PATHWAYS IN
MARKETING OF OTC DRUGS
4
AIMS AND OBJECTIVES
The main objective of this study is :
To assess the self – medication practise
 To identify most commonly used OTC drugs
 To assess common types of illness in people
5
LITERATURE REVIEW
 Finley et al 1997., studied Self-administration of Over-the-
counter Medication for pain among adolescent .
 Eric P. Brass 2001 ., studied Changing Status of Drugs from
Prescription to Over-the-Counter Availability.
 Verma Rohit K et. al 2010 ., self medication among
professional students in North India .
6
Sr. No. Various OTC drugs Brand names
1 Analgesics Saridon ,
Disprin
2 Antipyretics Crocin ,
Calpol
3 Cough Preparations Corex , Torex ,
Benadryl ,
D- Cold total
4 Antibiotics Amoxil ,
Trimox
5 Anti- allergics Cetzine ,
Levorid
6 Antacids Zentac ,
Gelusil
VARIOUS OTC DRUGS
7
 The Over-the-Counter (OTC) Drug Review was established to
evaluate the safety and effectiveness of OTC drug products marketed
in the United States before May 11, 1972
 It is a three-phase public rulemaking process (each phase requiring
a Federal Register publication) resulting in the establishment of
standards (drug monographs) for an OTC therapeutic drug class.
OTC DRUG REVIEW
DEVELOPMENT AND REGULATION OF
OTC (NONPRESCRIPTION) DRUG
PRODUCTS
8
 Over-the-counter (OTC) drugs are developed under the OTC
Monograph Process or through the New Drug Application (NDA)
Process.
 FDA's review of OTC drugs is primarily handled by the Center
for Drug Evaluation's Office of Drug Evaluation IV.
OTC DRUGS DEVELOPED UNDER
THE OTC DRUG MONOGRAPH
PROCESS
9
 Division of Nonprescription Drug Products (DNDP) is also
responsible for the development of the OTC drug monographs.
 Data supporting the safety and efficacy of OTC active ingredients
in a particular drug monograph are reviewed by appropriate scientific
personnel.
 Efficacy data may require the input of a Medical Officer and/or
Statistician from a prescription review division.
 Carcinogenicity or other animal toxicology data may require input
from a CDER pharmacologist. So, while DNDP is considered to be
the lead division in the development of an OTC drug monograph,
reviewers from multiple divisions within the Office of New Drugs
(OND) may be involved in this process.
10
 Although pre-approval by FDA for drugs marketed under a drug
monograph is not required, many companies seek assurance that the
product they intend to market under the drug monograph complies
with the regulations.
 These cases are primarily handled by DNDP unless consultation
with the Division of Unapproved Drugs and Labeling Compliance or
another review division is necessary.
 If a drug cannot comply with the drug monograph, an IND and
approved NDA is necessary before the drug product may be
marketed .
11
REQUIREMENTS OF OTC DRUG
MONOGRAPH
“Recipe book ” for marketing an OTC
drug „
A list and explanation of GRASE
conditions GRASE = Generally Recognized
As Safe and Effective
 GRASE active ingredients
1. dosage strength
2. dosage form
„ Labeling requirements
1. indications
2. warning & directions for use warning
 „ Final formulation testing
12
PLAN OF WORK
1. Data collection on use of OTC drugs through web survey
2. Interaction with people taking medicines without prescription
3. Adverse drug reaction caused due to use of OTC drugs
4. Survey on age groups relying on self- medication
5. Collection of information on most commonly used OTC drugs
nowadays
13
ADVANTAGES OF OTC DRUGS
 Convenient
 Economical
 Enable patients to control their own chronic
conditions
 Useful for mild illness
 Reduce the pressure on medical services where
health care personnel are insufficient
 Time saving
14
DISADVANTAGES OF OTC DRUGS
 Lack of knowledge about drug dose
 Adverse Drug Reactions
 Chances of using wrong medication
 Drugs interactions
15
REFERENCES
1. Christine T. Chambers, Graham J. Reid, Patrick J. McGrath, G.
Allen Finley, Self-administration of Over-the-counter
Medication for pain among adolescents ,Arch Pediatr Adolesc
Med. 1997;151(5):449-55.
2. Eric P. Brass ,Changing the Status of Drugs from Prescription
to Over-the-Counter Availability , N Engl J Med 2001;
345:810-816.
Thank you !!!....
16

Contenu connexe

Tendances

Post Marketing Drug Safety & Pharmacovigilance
Post Marketing Drug Safety & PharmacovigilancePost Marketing Drug Safety & Pharmacovigilance
Post Marketing Drug Safety & PharmacovigilanceMd. Zakaria Faruki
 
Generic drug approval in the United States - ANDA regulations
Generic drug approval in the United States - ANDA regulationsGeneric drug approval in the United States - ANDA regulations
Generic drug approval in the United States - ANDA regulationsSteve Zweig
 
postmarketing surviellance,,outsourcing of BA ,BE , CRO.
postmarketing surviellance,,outsourcing of BA ,BE , CRO. postmarketing surviellance,,outsourcing of BA ,BE , CRO.
postmarketing surviellance,,outsourcing of BA ,BE , CRO. supriyawable1
 
An overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different countryAn overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different countryNitin Patel
 
Non clinical drug development. ppt
Non clinical drug development. pptNon clinical drug development. ppt
Non clinical drug development. pptPRABU12345678
 
Regulatory requirements of eu & mhra trilok
Regulatory requirements of eu & mhra  trilokRegulatory requirements of eu & mhra  trilok
Regulatory requirements of eu & mhra trilokTrilok Shahare
 
Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...Dr Sukanta sen
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]Sagar Savale
 
Post marketing surveilance
Post marketing surveilancePost marketing surveilance
Post marketing surveilanceaiswarya thomas
 
importance of pharmcovigilance
importance of pharmcovigilanceimportance of pharmcovigilance
importance of pharmcovigilancesiddemsetty nikhil
 
Brand drug vs generic drug
Brand drug vs generic drugBrand drug vs generic drug
Brand drug vs generic drugShubham Paul
 
UNDERSTANDING GENERIC VS INNOVATOR BUSINESS
UNDERSTANDING GENERIC VS INNOVATOR BUSINESSUNDERSTANDING GENERIC VS INNOVATOR BUSINESS
UNDERSTANDING GENERIC VS INNOVATOR BUSINESSKabin Maleku
 
Inda, nda & anda concept
Inda, nda & anda conceptInda, nda & anda concept
Inda, nda & anda conceptKishanSundesha
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
PharmacovigilancePrasathP13
 
Drug development process and regulatory submissions
Drug development process and regulatory submissionsDrug development process and regulatory submissions
Drug development process and regulatory submissionsSuyog
 

Tendances (20)

Off label use of drugs
Off label use of drugsOff label use of drugs
Off label use of drugs
 
Post Marketing Drug Safety & Pharmacovigilance
Post Marketing Drug Safety & PharmacovigilancePost Marketing Drug Safety & Pharmacovigilance
Post Marketing Drug Safety & Pharmacovigilance
 
Off label use of antibiotics in pediatrics
Off label use of antibiotics in pediatricsOff label use of antibiotics in pediatrics
Off label use of antibiotics in pediatrics
 
Generic drug approval in the United States - ANDA regulations
Generic drug approval in the United States - ANDA regulationsGeneric drug approval in the United States - ANDA regulations
Generic drug approval in the United States - ANDA regulations
 
postmarketing surviellance,,outsourcing of BA ,BE , CRO.
postmarketing surviellance,,outsourcing of BA ,BE , CRO. postmarketing surviellance,,outsourcing of BA ,BE , CRO.
postmarketing surviellance,,outsourcing of BA ,BE , CRO.
 
An overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different countryAn overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different country
 
Anda
AndaAnda
Anda
 
Non clinical drug development. ppt
Non clinical drug development. pptNon clinical drug development. ppt
Non clinical drug development. ppt
 
Regulatory requirements of eu & mhra trilok
Regulatory requirements of eu & mhra  trilokRegulatory requirements of eu & mhra  trilok
Regulatory requirements of eu & mhra trilok
 
Anda.ppt
Anda.pptAnda.ppt
Anda.ppt
 
Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]
 
Post marketing surveilance
Post marketing surveilancePost marketing surveilance
Post marketing surveilance
 
importance of pharmcovigilance
importance of pharmcovigilanceimportance of pharmcovigilance
importance of pharmcovigilance
 
Brand drug vs generic drug
Brand drug vs generic drugBrand drug vs generic drug
Brand drug vs generic drug
 
UNDERSTANDING GENERIC VS INNOVATOR BUSINESS
UNDERSTANDING GENERIC VS INNOVATOR BUSINESSUNDERSTANDING GENERIC VS INNOVATOR BUSINESS
UNDERSTANDING GENERIC VS INNOVATOR BUSINESS
 
Inda, nda & anda concept
Inda, nda & anda conceptInda, nda & anda concept
Inda, nda & anda concept
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Intro pharma
Intro pharmaIntro pharma
Intro pharma
 
Drug development process and regulatory submissions
Drug development process and regulatory submissionsDrug development process and regulatory submissions
Drug development process and regulatory submissions
 

Similaire à Jatin singla

Over the Counter Drugs (OTC DRUGS)
Over the Counter Drugs (OTC DRUGS)Over the Counter Drugs (OTC DRUGS)
Over the Counter Drugs (OTC DRUGS)Umair hanif
 
rashmi presentation
rashmi presentationrashmi presentation
rashmi presentationRASHMINasare
 
Investigational new drug (IND)
Investigational new drug (IND)Investigational new drug (IND)
Investigational new drug (IND)Manish Rajput
 
Regulatory requirements for drug approval
Regulatory requirements for drug approval Regulatory requirements for drug approval
Regulatory requirements for drug approval Namdeo Shinde
 
MHRA and USFDA simultaneously data
MHRA and USFDA simultaneously dataMHRA and USFDA simultaneously data
MHRA and USFDA simultaneously data66VaibhavWaghchaure
 
INVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATIONINVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATIONBindu Kshtriya
 
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...Audumbar Mali
 
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIRegulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIJafarali Masi
 
RegulatoryIssues In Drug management cycle
RegulatoryIssues In Drug management cycleRegulatoryIssues In Drug management cycle
RegulatoryIssues In Drug management cycleHarunMohamed7
 
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiaOverview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiashabana parveen
 
investigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptxinvestigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptxPharmacy
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and developmentSujith Thokala
 
Investigational new drug application new
Investigational new drug application newInvestigational new drug application new
Investigational new drug application newAakrati Gupta
 
POST MARKETING SURVEILLANCE.pptx
POST MARKETING SURVEILLANCE.pptxPOST MARKETING SURVEILLANCE.pptx
POST MARKETING SURVEILLANCE.pptxSundarKaruna
 
Japan drug and cosmetics regulation.pdf
 Japan drug and cosmetics  regulation.pdf Japan drug and cosmetics  regulation.pdf
Japan drug and cosmetics regulation.pdfBhavikaAPatel
 

Similaire à Jatin singla (20)

Over the Counter Drugs (OTC DRUGS)
Over the Counter Drugs (OTC DRUGS)Over the Counter Drugs (OTC DRUGS)
Over the Counter Drugs (OTC DRUGS)
 
rashmi presentation
rashmi presentationrashmi presentation
rashmi presentation
 
Otc drugs
Otc drugsOtc drugs
Otc drugs
 
2003
20032003
2003
 
Investigational new drug (IND)
Investigational new drug (IND)Investigational new drug (IND)
Investigational new drug (IND)
 
Regulatory requirements for drug approval
Regulatory requirements for drug approval Regulatory requirements for drug approval
Regulatory requirements for drug approval
 
MHRA and USFDA simultaneously data
MHRA and USFDA simultaneously dataMHRA and USFDA simultaneously data
MHRA and USFDA simultaneously data
 
INVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATIONINVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATION
 
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
 
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIRegulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy II
 
Otc drugs use & sales
Otc drugs use & salesOtc drugs use & sales
Otc drugs use & sales
 
RegulatoryIssues In Drug management cycle
RegulatoryIssues In Drug management cycleRegulatoryIssues In Drug management cycle
RegulatoryIssues In Drug management cycle
 
Pharmacovigilance: A review
Pharmacovigilance: A reviewPharmacovigilance: A review
Pharmacovigilance: A review
 
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiaOverview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,india
 
investigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptxinvestigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptx
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 
Investigational new drug application new
Investigational new drug application newInvestigational new drug application new
Investigational new drug application new
 
POST MARKETING SURVEILLANCE.pptx
POST MARKETING SURVEILLANCE.pptxPOST MARKETING SURVEILLANCE.pptx
POST MARKETING SURVEILLANCE.pptx
 
Japan drug and cosmetics regulation.pdf
 Japan drug and cosmetics  regulation.pdf Japan drug and cosmetics  regulation.pdf
Japan drug and cosmetics regulation.pdf
 
Nda
NdaNda
Nda
 

Plus de jatin singla

Plus de jatin singla (20)

Non linear pharmacokinetics.
Non linear pharmacokinetics.Non linear pharmacokinetics.
Non linear pharmacokinetics.
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin
JatinJatin
Jatin
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin
JatinJatin
Jatin
 
Singla
SinglaSingla
Singla
 
Jatin singla
Jatin singlaJatin singla
Jatin singla
 
Jatin singla (2)
Jatin singla (2)Jatin singla (2)
Jatin singla (2)
 
Jatin singla project ppt
Jatin singla project pptJatin singla project ppt
Jatin singla project ppt
 
Jatin industrial ppt
Jatin industrial  pptJatin industrial  ppt
Jatin industrial ppt
 
regulation of herbal products
regulation of herbal productsregulation of herbal products
regulation of herbal products
 
Jatin an overview of sunscreen regulations in the world
Jatin  an overview of sunscreen regulations in the worldJatin  an overview of sunscreen regulations in the world
Jatin an overview of sunscreen regulations in the world
 
Jatin article qbd
Jatin article qbdJatin article qbd
Jatin article qbd
 
Multiple emulsion
Multiple emulsionMultiple emulsion
Multiple emulsion
 
Jatin. biovailability
Jatin. biovailabilityJatin. biovailability
Jatin. biovailability
 
Jatin validation
Jatin validationJatin validation
Jatin validation
 
Jatin ivivc
Jatin ivivcJatin ivivc
Jatin ivivc
 

Dernier

APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024Janet Corral
 

Dernier (20)

APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 

Jatin singla

  • 1. 1 Marketing project report on customer behaviour towards use of various Over the counter (OTC) medicines
  • 2. INTRODUCTION  Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription, from a healthcare professional, as compared to prescription drugs , which may be sold only to consumers possessing a valid prescription.  OTC drugs are selected by a regulatory agency to ensure that they are ingredients that are safe and effective when used without a physician's care. 2
  • 3. 3 Two post-1938 regulatory pathways exist for the legal marketing of OTC products: 1. marketing in compliance with an OTC drug monograph 2. marketing under the authority of an approved product-specific new drug application (NDA), or an abbreviated new drug application (ANDA) REGULATORY PATHWAYS IN MARKETING OF OTC DRUGS
  • 4. 4 AIMS AND OBJECTIVES The main objective of this study is : To assess the self – medication practise  To identify most commonly used OTC drugs  To assess common types of illness in people
  • 5. 5 LITERATURE REVIEW  Finley et al 1997., studied Self-administration of Over-the- counter Medication for pain among adolescent .  Eric P. Brass 2001 ., studied Changing Status of Drugs from Prescription to Over-the-Counter Availability.  Verma Rohit K et. al 2010 ., self medication among professional students in North India .
  • 6. 6 Sr. No. Various OTC drugs Brand names 1 Analgesics Saridon , Disprin 2 Antipyretics Crocin , Calpol 3 Cough Preparations Corex , Torex , Benadryl , D- Cold total 4 Antibiotics Amoxil , Trimox 5 Anti- allergics Cetzine , Levorid 6 Antacids Zentac , Gelusil VARIOUS OTC DRUGS
  • 7. 7  The Over-the-Counter (OTC) Drug Review was established to evaluate the safety and effectiveness of OTC drug products marketed in the United States before May 11, 1972  It is a three-phase public rulemaking process (each phase requiring a Federal Register publication) resulting in the establishment of standards (drug monographs) for an OTC therapeutic drug class. OTC DRUG REVIEW
  • 8. DEVELOPMENT AND REGULATION OF OTC (NONPRESCRIPTION) DRUG PRODUCTS 8  Over-the-counter (OTC) drugs are developed under the OTC Monograph Process or through the New Drug Application (NDA) Process.  FDA's review of OTC drugs is primarily handled by the Center for Drug Evaluation's Office of Drug Evaluation IV.
  • 9. OTC DRUGS DEVELOPED UNDER THE OTC DRUG MONOGRAPH PROCESS 9  Division of Nonprescription Drug Products (DNDP) is also responsible for the development of the OTC drug monographs.  Data supporting the safety and efficacy of OTC active ingredients in a particular drug monograph are reviewed by appropriate scientific personnel.  Efficacy data may require the input of a Medical Officer and/or Statistician from a prescription review division.  Carcinogenicity or other animal toxicology data may require input from a CDER pharmacologist. So, while DNDP is considered to be the lead division in the development of an OTC drug monograph, reviewers from multiple divisions within the Office of New Drugs (OND) may be involved in this process.
  • 10. 10  Although pre-approval by FDA for drugs marketed under a drug monograph is not required, many companies seek assurance that the product they intend to market under the drug monograph complies with the regulations.  These cases are primarily handled by DNDP unless consultation with the Division of Unapproved Drugs and Labeling Compliance or another review division is necessary.  If a drug cannot comply with the drug monograph, an IND and approved NDA is necessary before the drug product may be marketed .
  • 11. 11 REQUIREMENTS OF OTC DRUG MONOGRAPH “Recipe book ” for marketing an OTC drug „ A list and explanation of GRASE conditions GRASE = Generally Recognized As Safe and Effective  GRASE active ingredients 1. dosage strength 2. dosage form „ Labeling requirements 1. indications 2. warning & directions for use warning  „ Final formulation testing
  • 12. 12 PLAN OF WORK 1. Data collection on use of OTC drugs through web survey 2. Interaction with people taking medicines without prescription 3. Adverse drug reaction caused due to use of OTC drugs 4. Survey on age groups relying on self- medication 5. Collection of information on most commonly used OTC drugs nowadays
  • 13. 13 ADVANTAGES OF OTC DRUGS  Convenient  Economical  Enable patients to control their own chronic conditions  Useful for mild illness  Reduce the pressure on medical services where health care personnel are insufficient  Time saving
  • 14. 14 DISADVANTAGES OF OTC DRUGS  Lack of knowledge about drug dose  Adverse Drug Reactions  Chances of using wrong medication  Drugs interactions
  • 15. 15 REFERENCES 1. Christine T. Chambers, Graham J. Reid, Patrick J. McGrath, G. Allen Finley, Self-administration of Over-the-counter Medication for pain among adolescents ,Arch Pediatr Adolesc Med. 1997;151(5):449-55. 2. Eric P. Brass ,Changing the Status of Drugs from Prescription to Over-the-Counter Availability , N Engl J Med 2001; 345:810-816.